Dr Reddy’s Laboratories announces the launch of Invista (dasatinib) in India EP News Bureau Apr 13, 2020 It is indicated for the treatment of chronic accelerated or myeloid or lymphoid blast phase and newly diagnosed in chronic phase…
Bullish on India Viveka Roychowdhury Apr 21, 2015 Since 2013, Novartis has sharpened focus, with last April's asset swaps with GSK and Eli Lilly the next step in this process. In…
